Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
CVS is working with advisors on strategic review, sources say
GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
Major CVS shareholder plans activist push, will meet with management, sources say
Harris leads with Latino voters, but the economy narrows the margin for Dems: Survey
10 things to watch in the stock market Friday including a bullish call on Best Buy
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
